Abstract

Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2006 - Veterinary Compounding

Page(s): 446-448

Download in electronic PDF format for $75
  • Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Page 1
  • Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Page 2
  • Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Page 3

Abstract

National Institute of Occupational Safety and Health Publication No. 2004–165, Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings, was published in 2004 to increase the awareness of healthcare workers and other professionals about the health risks of working with hazardous drugs and to provide measures for protecting their health. The health risks to employees who prepare or administer hazardous drugs in the workplace is influenced by many factors, and each compounding facility is responsible for developing its own list of hazardous drugs and for creating standard operating procedures to reduce risks as much as possible for employees. To provide employees with the greatest protection, employers should (1) implement necessary administrative and engineering controls, and (2) assure that the workers use sound procedures and proper protective equipment for handling hazardous drugs.

Related Keywords

  • United States Pharmacopeia
  • hazardous drugs
  • drug safety
  • compounded sterile preparations
  • chemotherapy agents
  • drug contamination
  • regulation
  • Occupational Safety and Health Administration
  • OSHA
  • National Institute for Occupational Safety and Health
  • NIOSH
  • employee exposures
  • safe workplace

Related Categories

  • LEGAL
  • QUALITY CONTROL
  • PROFESSIONAL ISSUES
  • HAZARDOUS DRUGS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2006
Pg. 446-448
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Jan/Feb 2009
Pg. 56-62
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2019
Pg. 182-186
How to Develop and Maintain a Hazardous Drug List
Author(s): Dillon L Rad
Nov/Dec 2020
Pg. 451-458
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
May/Jun 2013
Pg. 182-190
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Author(s): Mixon Bill, Nain John
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Jul/Aug 2009
Pg. 300-310
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting
Author(s): McElhiney Linda F
Sep/Oct 2020
Pg. 371-379
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2022
Pg. 358-362
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Author(s): Lopez C Vidal, Rios GL Quito
Mar/Apr 2007
Pg. 149-151
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Author(s): Allen Loyd V Jr
Sep/Oct 2006
Pg. 377-379
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 456-460
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Author(s): Lyon Joanna
Sep/Oct 2014
Pg. 358-364
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Author(s): Palma Elisabetta, Bufarini Celestino
Jul/Aug 2020
Pg. 270-276
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2021
Pg. 358-362
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Author(s): Cabaleiro Joe
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D